Status:
ACTIVE_NOT_RECRUITING
Evaluating the Use of a Remote Telehome Monitoring Hypertension Program for Patients Receiving Virtual Care
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
High blood pressure or hypertension (HTN) is very common and can lead to serious health issues and even death. Medications and lifestyle changes can be used to treat HTN. During the Coronavirus Diseas...
Eligibility Criteria
Inclusion
- Have a diagnosis of primary, essential HTN (SBP\>140/90mmHg or \>130/80mmHg for diabetes)
- Have access to a phone (can be a landline)
- Have access to cellular (4G) network at their primary residence (they do not need to physically own a cellular phone but the need to be able to confirm their residence has 4G network access in order to connect the Aetonix aTouchAway platform to the network)
- Speak English or French
Exclusion
- Patients who have been referred or who are actively managed at a specialized HTN clinic or other Telehome monitoring program
- Women who are pregnant, breastfeeding or planning to become pregnant
- Patients who are institutionalized at a retirement home, nursing home or long-term care facility
- Patients who plan on travelling out of the country for more than 2 weeks at any point during the intervention phase of the study (first 3 months)
- Patients who are cognitively impaired or experiencing acute psychiatric illness that would alter their ability to participate
Key Trial Info
Start Date :
August 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05300503
Start Date
August 4 2022
End Date
January 1 2026
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7